Home > Industry Projects > Europe > Boehringer Ingelheim Biopharmaceutical Production
The expansion of the Vienna facility has required a total investment of more than €80 million. It is the company’s largest single investment at its Austrian subsidiary.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
